Daratumumab in combination for treating newly diagnosed systemic amyloid light-chain amyloidosis

Supporting evidence

• Evaluation report

• Draft guidance consultation committee papers (PDF 4.28 MB)

  Published:

  27 March 2024

• Final guidance committee papers 1 (PDF 835 KB)

  Published:

  27 March 2024

• Final guidance committee papers 2 (PDF 1.04 MB)

  Published:

  27 March 2024